Acute uveitis: A rare adverse effect of miltefosine in the treatment of post-kala-azar dermal leishmaniasis
Rev. Soc. Bras. Med. Trop
; Rev. Soc. Bras. Med. Trop;54: e20200208, 2021. graf
Article
de En
| SES-SP, ColecionaSUS, LILACS
| ID: biblio-1143878
Bibliothèque responsable:
BR1.1
ABSTRACT
Abstract Post-kala-azar dermal leishmaniasis is a skin disorder occurring in 5-10% of visceral leishmaniasis patients after treatment with miltefosine,the first-line drug for this skin disorder. We reported a case of acute anterior uveitis,a rare adverse effect, experienced by a patient treated with miltefosine for post-kala-azar dermal leishmaniasis. This adverse effect developed after 15 days of miltefosine consumption, and the patient himself discontinued the treatment. The ophthalmic complication was completely resolved with antibiotics and steroid eye drops. After recovery from the ophthalmic complication, the patient was successfully treated with liposomal amphotericin B for the skin lesions.
Mots clés
Texte intégral:
1
Indice:
LILACS
Sujet Principal:
Uvéite
/
Leishmaniose cutanée
/
Leishmaniose viscérale
/
Antiprotozoaires
Limites du sujet:
Humans
langue:
En
Texte intégral:
Rev. Soc. Bras. Med. Trop
Thème du journal:
MEDICINA TROPICAL
Année:
2021
Type:
Article